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ABSTRACT The effects of ethanolic extract of Azadirachta indica leaves on lipid peroxidation 
and serum lipids of alloxan-induced diabetic rats were examined to assess the role of the extract 
in the management diabetic complications. Serum Malondialdehyde (MDA), total cholesterol, 
triglyceride and blood glucose were measured in diabetic and normal rats with or without 400 
mg/kg leaf extract of A. indica. The result showed that blood glucose, total cholesterol (TC), 
triglyceride and MDA concentrations in serum of untreated diabetic rats were significantly 
(P<0.05) higher than that of normal control and diabetic rats treated with the extracts. The 
extract caused a 55.8%, 27.1%, 16.8% and 64.7% reduction in blood glucose, TC, TG and MDA 
respectively when compared to untreated diabetic rats. The extract also demonstrated growth 
promoting effect on normal and diabetic rats. The anti-lipid peroxidative, antihyperglycaemic 
and serum lipid modulating activities justify the possible use of extract of A. indica leaves in the 






Lipid peroxidation, a known mechanism of cellular injury, is 
a chain reaction initiated by oxidant radicals. It is an index of 
oxidative stress in cells and tissues. The free radical oxidation 
of lipid molecules proceeds from the fatty acylmethylene 
group adjacent to a double bond (Frankel 1980) to form 
lipid hydroperoxides which are capable of further reactions 
to yield various classes of peroxides. Lipid peroxides are 
unstable and decompose to form series of complex products 
including reactive carbonyl compounds. Polyunsaturated fatty 
acids on oxidation decompose to malondialdehyde (MDA) 
and 4-hydroxyalkenals (HAE). The levels of these products 
in serum or tissues have been widely accepted as a measure 
of lipid peroxidation.
Biological membranes which contain phospholipids rich 
in polyunsaturated fatty acids are continuously being oxidized 
by superoxides, hydroperoxyl and peroxyl radicals emanat­
ing from exposures to radiations and oxidative reactions 
involving endogenous and exogenous compounds in the body 
(Droge 2002). There are, however, some defense systems to 
prevent injury caused by these free radicals (Hensley et al. 
2000). These systems include antioxidant vitamins, reduced 
glutathione, transport and storage proteins for binding diva­
lent metal irons, and antioxidant enzymes. Oxidative stress 
which is associated with cellular injury in many pathological 
conditions occurs when there is an imbalance between free- 
radical generating and radical scavenging systems (Hensley 
et al. 2000).
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The complications of diabetes mellitus are morphologic 
consequences of many metabolic pathways which may be 
associated with increased free radicals and serum lipid 
production (Lee and Chung 1999; Sheetz and King 2002; 
Goldberg 2001; Smaoui et al 2004). Intracellular advanced 
glycated end products (AGE) may stimulate the generation 
of increased level of reactive oxygen species (ROS) and the 
activation of NF-kB following binding to specific recep­
tors (Kahler et al. 1993; Stitt et al. 2002). Glucose can be 
converted to Sorbitol by the enzyme, aldose reductase and 
eventually to fructose. In this process, intracellular NADPH 
is used as cofactor and this reduces the availability of NADPH 
required for the regeneration of reduced glutathione (GSH), 
a major antioxidant molecule in cells and tissues (Lee and 
Chung 1999). Sustained hyperglycemia as in diabetes mellitus 
and progressive depletion of intracellular NADPH by aldose 
reductase may lead to a compromise of GSH regeneration 
and thus increase cellular susceptibility to oxidative stress. 
Protein glycosylation in cells also affect antioxidant reactions 
catalysed by ROS scavenging enzymes in diabetes mellitus 
(Stitt et al. 2002).
Accelerated atherosclerosis among diabetics is a major 
pathologic cause of microvascular and macrovascular com­
plications resulting in increased risk of myocardial infarction, 
stroke and lower extremity gangrene. Experimental and clini­
cal evidences suggest that these complications are promoted 
by dyslipidemia (Goldberg 2001). Defects in insulin action 
have been shown to be responsible for the changes in plasma 
lipoprotein fractions in patients with diabetes mellitus (Haff-
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ner et al. 2000).The oxidized form of low density lipoprotein 
(LDL)-cholesterol is of prime importance in the formation of 
foam cells in atherosclerotic plaque (Jilial and Devaraj 1996). 
Chemical changes of LDL- cholesterol by free radicals gener­
ated in macrophages or endothelial cells in the arterial wall 
yields oxidize LDL thereby implicating oxidative stress in the 
pathogenesis of atherosclerosis (Reardon and Getz 2001). An­
tioxidant treatment has however been shown to protect against 
the development of atherosclerosis in hypercholesterolemic 
experimental animals (Reardon and Getz 2001) and diabetic 
models (Jilial et al. 1990; Jilial and Grundy 1992).
Azadirachta indica, also called neem, belongs to the fam­
ily of meliacea. It is one of the most useful medicinal plants 
with anti-inflammatory, antibacterial, anti-parasitic and im­
munomodulatory activities (Kausik and Ranajet 2002). Blood 
glucose lowering effect of Azadirachta indica seed oil and 
water extract have been reported in various models of diabetic 
animals (Dixit et al. 1986; Khosla et al. 2000; Halim 2003; 
Gupta et al. 204). The leaf extract of A. indica have been 
used traditionally in the control of diabetes mellitus in many 
countries including Nigeria, however, scientific studies on 
the efficacy and its mechanism of action have not been fully 
investigated.
This study therefore examines the effects of ethanolic ex­
tract of A. indica leaves on lipid peroxidation and serum lipids 
in diabetic rats with a view to ascertaining its involvement in 
the management of oxidative stress and other complications 
associated with diabetic mellitus.
Materials and Methods
Plant materials and extract preparation
Fresh matured leaves of Azadirachta indica (Neem) were 
harvested from Endocrine Research Farm of the Department 
of Biochemistry, University of Calabar, Calabar. The leaves 
were washed with tap water, rinsed with distilled water and 
sundried to remove traces of water. The leaves were ground 
to form paste with an electric blender (Binatone, Japan). One 
hundred and fifty grams of leaf paste was agitated in 500 ml 
of ethanol and stored overnight in a refrigerator at 4°C for 
complete extraction. The suspension was filtered and 50 ml 
aliquots of the filtrate were poured into separate beakers of 
known weight. The aliquots were dried at 50°C to constant 
weight using rotary evaporator. The dry extract was stored in 
a refrigerator at 4°C. Two grams of the dry extract was resus­
pended daily in 50 ml of distilled water for administration to 
the animals. 1.5 ml of the suspension, given to a 150 g rat was 
equivalent to 400 mg extract per kilogram body weight. The 
volumes of extract suspension were adjusted accordingly for 
various weights of the rats.
Animals
Thirty albino wistarrats, weighing 150-200 g, were obtained
from the Animal House of the Department of Biochemistry, 
University of Calabar. The animals were kept in standards 
plastic cages and placed in a well ventilated room of tempera­
ture between 22°C and 27°C. The animals were acclimatized 
for seven days. During this time and throughout the experi­
mental period, they were fed with commercial rat feed (Pfizer 
Livestock Co. Ltd, Aba, Nigeria) and tap water ad libitum .
Animal treatments
After acclimatization, the animals were assigned into four 
groups of six rats each as follows: Normal Control (NC), 
Diabetic Control (DC), Diabetic Treated (DT) and Normal 
Treated (NT) groups. The animals for DC and DT groups 
were made diabetic by a single intraperitoneal administration 
of 150 mg/kg body weight of alloxan (Sigma, St. Louis, USA) 
dissolved in distilled water (Battel et al. 1999). The animals 
were left for 7 days after which fasting glucose concentrations 
were determined in their tail-prick blood samples using One 
Touch Basic Glucometer (Life Scan, USA). Animals with 
consistent blood glucose greater than 200 mg/dl for 2 days 
were considered diabetic and randomly assigned to DC or DT 
group before administration of extract commenced. Groups 
DT and NT were treated with 400 mg/kg body weight of the 
extract twice daily for 7 days by oral gavage while groups 
DC and NC which served as controls were given distilled 
water orally. Body weight of the animals and their fasting 
blood glucose were monitored before and after extract ad­
ministration.
Collection and preparation of samples
At the end of the 7-day treatment, the animals were anaes- 
thesized under chloroform vapour and sacrificed. Blood 
samples were obtained by cardiac puncture and poured into 
plain screw-caped sample bottles and allowed to clot. Serum 
samples were separated from the clotted blood by centrifuga­
tion at 2000 x g for 5 min using an MSE model (England) 
bench centrifuge. The sera were stored at 4°C and biochemi­
cal assays conducted within 24 h.
Biochemical assays
Blood glucose was determined by pricking the tail of rats 
asceptically with Lancet and placing one drop of blood on 
a sample strip. The blood on the strip was inserted into the 
glucometer (Life Scan, USA) and glucose concentration was 
read (WHO, 1980)
Lipid peroxidation product, malondialdehyde (MDA) 
was measured by the method of Esterbauer et al (1991) using 
Bioxytech MDA reagents kit.
Total cholesterol and triglyceride concentrations were de­
termined by enzymatic colourimetric assay using reagents kits 
from Dialab produktion, France. The absorbances in all analy­
sis were read using spectrophotometer Optima SP-300.
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% Weight gain Before After
NC 180.2+ 5.15 183.5+ 8.92 1.83 + 0.31 106.6 + 15.10 104.8+ 18.10
DC 179.3+ 6.10 181.0+8.25 0.95 + 0.42* 300.4 + 10.46* 306.5 + 12.43
DT 177.5+ 6.50 181.1+9.50 2.03 + 0.35 302.6 + 16.48* 133.8+ 13.75
NT 179.4+ 4.25 185.5+8.20 3.40 + 0.51* 105.5 + 18.20 104.5 + 16.50
Mean + SD, *Significantly different from normal control atP< 0.05.
Table 2. Malondialdehyde (MDA), total cholesterol (TC) and 
triglyceride (TG) in serum of normal and diabetic rats on or 
without extract of A. indica.
Group MDA (^mol/ml) TC (mg/dl) TG (mg/dl)
NC 2.07 + 0.42 92.10 + 6.17 114.20 + 6.24
DC 11.51 + 0.22* 132.00 + 7.82* 145.71 + 8.34*
DT 4.06 + 0.43 96.24 + 3.42 121.31 + 7.63
NT 94.37 + 3.47 110.56 + 5.16
Mean + SD, *significantly different from normal control atP< 0.05.
Statistical Analysis
Data are presented as mean ± SD. The differences between 
groups were tested using student’s i-test. A probability of 0.05 
was chosen as a level of signihcance.
Results and Discussion
The mean values of body weight and blood glucose of normal 
and diabetic rats before and after treatment with 400 mg/kg 
of A. indica leaf extract is presented in Table 1, while Table 
2 shows the effects of the extract on serum malondialdehyde 
(MDA) and serum lipids of normal and diabetic rats. The 
percentage weight gain of diabetic and normal rats treated 
with the extract of A. indica leaves were respectively higher 
than those of diabetic and normal control rats which did not 
receive the extract. Serum glucose, cholesterol and triglyc­
eride concentrations were signihcantly (P <0.05) higher in 
diabetic control rats compared to those of normal control and 
those receiving extract treatment.
The extract reduced serum glucose, cholesterol and 
triglyceride concentrations in diabetic rats to about normal 
levels and also appeared to promote growth of both normal 
and diabetic rats. The mechanism of growth promotion by 
the extract is not well known, but may be related to enhanced 
cellular anabolic processes in which carbohydrates, proteins 
and lipids are metabolized and stored in tissues. Insulin, a 
hormone with known anabolic activity, enhances peripheral 
uptake of glucose and triglyceride from extracellular com­
partment into cells (Saltiel and Kahn 2001). Thus increase in 
weight of animals treated with the extract may be the result 
of enhanced insulin action, especially since extract treatment
caused the reduction of serum glucose, cholesterol and tri­
glyceride in the diabetic rats.
The lipid peroxidation product, malondialdehyde (MDA), 
was signihcantly (P<0.05) higher in the diabetic control rats 
compared to normal control whereas the MDA of diabetic 
treated rats was not signihcantly different from those of nor­
mal control. This indicates that the extract of A. indica pre­
vents lipid peroxidation reactions in the animals. Fresh mature 
leaves of A. indica have been shown to contain quecretin (a 
poly-phenolic havonoid), nimbosterol (P-sitosterol), caro­
tenes and ascorbic acid (Jacobson 1990). Thus, the prevention 
of lipid peroxidation by the leaf extract could be attributed 
to the antioxidant activities of the havonoid, carotenes and 
ascorbic acid present in the leaves.
Alloxan used in this study for the induction of diabetes 
mellitus is known to mediate the destruction of P-cells by 
establishing redox cycles resulting in the formation of reac­
tive free radicals which constitute the major inducer agent for 
the cell damage and hence diabetes in the rats (Szkuldeshi 
2001). The alloxan associated radicals and those generated 
as a result of hyperglycemia by aldose reductase (Ceriello et 
al. 1992) and AGE-related (Wolff et al. 1991) activities may 
be responsible for the increased lipid peroxidation observed 
in the diabetic control rats. Earlier reports have demonstrated 
elevated serum lipid peroxides levels and diminished antioxi­
dant status in diabetic subjects (Oberley 1988). It is likely that 
administration of the extract prevents further destruction of 
P-cells by terminating the progressive generation of reactive 
hydroperoxyl radicals. This reduction of lipid peroxidation by 
the extract appeared to allow for cellular repair and regenera­
tion of P-cells which result in production of insulin as may 
be evident by the reduction of blood glucose, triglyceride and 
cholesterol in the diabetic treated rats.
Diabetes mellitus and its complications are associated 
with free radical mediated celluar injury (Asayama et al. 
1993; Lee and Chung 1999) and impaired lipid metabolism 
(Goldberg 2001). This study have shown that ethanolic ex­
tract of A. indica leaves demonstrated anti-lipid peroxidative, 
anti-hyperglycemic, and anti-hypercholesterolemic activities 
and reduced triglyceride level in diabetic rat model, therefore 
justifying the possibility of using the extract in management 
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